Aim: The fragmentation characteristics of cell-free DNA (cfDNA) are informative biomarkers in liquid biopsies, including non-invasive prenatal testing (NIPT), as they provide insights into the origins of the cfDNA. Viral infections by DNA viruses can contribute to the available cfDNA in these samples. Here, we characterize the fragment size distribution of viral cfDNA fragments obtained from available anonymous NIPT samples.Methods: A viral database of 224 DNA viruses was generated from the NCBI RefSeq viral database. Paired-end cfDNA sequencing reads from 83.522 NIPT samples that did not map to any of the human chromosomes, or mitochondrial DNA of the human reference genome build GRCh38 (excluding alternative and unplaced contigs) were rem...
Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasm...
Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on genomic alter...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Aim: The fragmentation characteristics of cell-free DNA (cfDNA) are informative biomarkers in liquid...
The release of fetoplacental cell-free DNA (cfDNA) into the maternal bloodstream opened up new avenu...
To unequivocally address their unresolved intimate structures in blood, we scrutinized the size dist...
BACKGROUND: High-throughput sequencing of cell-free DNA fragments found in human plasma has been use...
Analysis of cell-free DNA (cfDNA) in the blood has shown promise for monitoring a variety of biologi...
Cell-free DNA molecules are released into the plasma via apoptotic or necrotic events and active rel...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Background: Assays that account for the biological properties and fragmentation of cell-free DNA (cf...
Noninvasive sampling of an individual’s body fluids is an easy means to capture circulating cell-fre...
Circulating tumor DNA (ctDNA) in blood plasma is present at very low concentrations compared to cell...
Thesis (Ph.D.)--University of Washington, 2016-03When cells die, they don’t simply vanish without a ...
Circulating cell-free DNA (cfDNA) has become a promising biomarker in prenatal diagnosis. However, d...
Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasm...
Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on genomic alter...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Aim: The fragmentation characteristics of cell-free DNA (cfDNA) are informative biomarkers in liquid...
The release of fetoplacental cell-free DNA (cfDNA) into the maternal bloodstream opened up new avenu...
To unequivocally address their unresolved intimate structures in blood, we scrutinized the size dist...
BACKGROUND: High-throughput sequencing of cell-free DNA fragments found in human plasma has been use...
Analysis of cell-free DNA (cfDNA) in the blood has shown promise for monitoring a variety of biologi...
Cell-free DNA molecules are released into the plasma via apoptotic or necrotic events and active rel...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...
Background: Assays that account for the biological properties and fragmentation of cell-free DNA (cf...
Noninvasive sampling of an individual’s body fluids is an easy means to capture circulating cell-fre...
Circulating tumor DNA (ctDNA) in blood plasma is present at very low concentrations compared to cell...
Thesis (Ph.D.)--University of Washington, 2016-03When cells die, they don’t simply vanish without a ...
Circulating cell-free DNA (cfDNA) has become a promising biomarker in prenatal diagnosis. However, d...
Cell-free DNA (cfDNA) is short, extracellular, fragmented double-stranded DNA found in plasma. Plasm...
Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on genomic alter...
Cell-free DNA (cfDNA) emerges as a promising liquid biopsy biomarker for cancer diagnosis and patien...